1. Rise in an aging population is one of the key factors driving the bio-implants market due to the fact that aged people are more susceptible to chronic diseases.
2. North America has the largest market for bio-implants, followed by Europe.
3. The bio-implants market in Asia is expected to experience a high growth rate in the next few years due to developing healthcare infrastructures and rising disposable income, among other factors.
4. However, the high cost of implants and reimbursement issues are some factors that may inhibit the growth of the market.
5. Major companies in the market include Boston Scientific, Endo Health Solutions, LifeNet Health, Orthofix and Stryker.
More articles on devices:
Aurora Spine gets CE Mark for TiNano implants: 5 key notes
Stryker, Arthrex named among best companies to work for in the US: 5 notes
NuVasive names chief information officer to help execute strategic goals: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
